Clinical Trial Update: Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating a combination regimen (methotrexate, mannitol, rituximab, and carboplatin) for newly diagnosed primary central nervous sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• METHOTREXATE (METHOTREXATE)
• Mannitol (mannitol)
• Rituximab (rituximab)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Central Nervous System Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN